Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis?

Ayan, A.; ERDEMCİ, Burak; Orsal, E.; Bayraktutan, Zafer; AKPINAR, Erol; Topcu, A.; Turkeli, Mehmet; Seven, B.

doi:10.1016/j.remn.2015.09.002

Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis?

Atıf İçin Kopyala

Ayan A. K., ERDEMCİ B., Orsal E., Bayraktutan Z., AKPINAR E., Topcu A., ...Daha Fazla

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, cilt.35, sa.2, ss.102-106, 2016 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 35 Sayı: 2
Basım Tarihi: 2016
Doi Numarası: 10.1016/j.remn.2015.09.002
Dergi Adı: REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.102-106
Anahtar Kelimeler: Lung cancer, Bone metastasis, Positron emission tomography, CEA, OPN, POSITRON EMISSION TOMOGRAPHY, TUMOR-MARKERS, SKELETAL METASTASES, DIAGNOSTIC-VALUE, CYFRA 21-1, OSTEOPONTIN, VARIANTS, PET/CT, ACID
Atatürk Üniversitesi Adresli: Evet

Özet

Objective: In this study, an evaluation was made of the relationship between the serum levels of carcinoembryonic antigen (CEA), osteopontin (OPN), and the semi-quantitative parameters of 18-fluoro2-deoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) in lung cancer patients with bone metastasis.